Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy
Geert C. van Almen, Melissa Swinnen, Paolo Carai, Wouter Verhesen, Jack P.M. Cleutjens, Jan D’hooge, Fons K. Verheyen, Yigal M. Pinto, Blanche Schroen, Peter Carmeliet, Stéphane Heymans (2011). Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy. , 51(3), DOI: https://doi.org/10.1016/j.yjmcc.2011.05.010.
